data_2n2f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n2f _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.101 0 CA-C-O 118.898 -0.946 . . . . 0.0 115.31 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -127.28 13.42 7.14 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 119.025 1.412 . . . . 0.0 112.924 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -70.02 -9.64 55.97 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 119.451 -2.031 . . . . 0.0 111.317 158.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -46.4 -20.27 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.558 2.743 . . . . 0.0 115.337 161.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -48.68 -22.93 0.87 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.653 1.581 . . . . 0.0 114.412 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -129.97 134.44 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.328 1.051 . . . . 0.0 108.932 152.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? 60.29 72.27 0.76 Allowed Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.487 2.315 . . . . 0.0 112.586 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.66 22.47 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.41 4.073 . . . . 0.0 115.798 -174.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? . . . . . 0 CA--C 1.547 0.847 0 O-C-N 120.54 -1.35 . . . . 0.0 112.745 170.231 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.137 0 N-CA-C 115.775 1.07 . . . . 0.0 115.775 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -116.19 -20.9 9.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.779 1.632 . . . . 0.0 111.815 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.95 -11.36 2.34 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.963 -1.086 . . . . 0.0 112.983 166.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -41.36 -15.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.849 2.059 . . . . 0.0 116.109 153.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -18.31 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.341 1.856 . . . . 0.0 115.722 171.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.2 pt -129.07 137.06 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 149.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 68.92 58.32 0.62 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.426 1.89 . . . . 0.0 113.338 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.24 40.98 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.876 1 C-N-CA 126.55 4.833 . . . . 0.0 114.715 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttp . . . . . 0 CA--C 1.545 0.771 0 C-N-CA 127.067 2.147 . . . . 0.0 111.455 175.497 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.299 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.738 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -121.29 -15.32 8.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.706 1.202 . . . . 0.0 112.837 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.7 -2.7 5.26 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.563 -1.336 . . . . 0.0 112.363 165.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -40.47 -23.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.892 2.877 . . . . 0.0 114.014 156.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -55.71 28.9 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 130.692 3.597 . . . . 0.0 115.784 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 mt 62.11 28.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.245 -2.159 . . . . 0.0 111.065 -176.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -115.26 60.73 1.41 Allowed Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 120.68 -1.263 . . . . 0.0 112.146 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -80.24 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 124.622 3.548 . . . . 0.0 113.437 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 CA--C 1.552 1.024 0 C-N-CA 125.537 1.535 . . . . 0.0 114.092 175.423 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -60.58 -16.49 38.49 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.5 mt -53.79 -12.22 0.5 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.692 1.197 . . . . 0.0 113.612 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -49.5 -16.16 0.19 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.413 1.485 . . . . 0.0 114.721 161.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -56.48 -28.71 60.46 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.555 1.142 . . . . 0.0 112.764 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 pt -169.76 113.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.18 2.192 . . . . 0.0 109.598 161.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 57.04 83.44 0.22 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.362 1.865 . . . . 0.0 112.275 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.26 1.52 4.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.195 3.263 . . . . 0.0 115.895 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttm . . . . . 0 N--CA 1.478 0.95 0 CA-C-N 120.416 1.462 . . . . 0.0 112.408 164.889 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.187 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -98.57 -3.72 35.69 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.348 2.074 . . . . 0.0 113.126 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.8 -7.23 32.25 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.594 -1.316 . . . . 0.0 112.332 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 5.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.559 2.344 . . . . 0.0 116.077 170.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -75.92 40.72 0.2 Allowed 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.116 -1.615 . . . . 0.0 115.04 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.341 36.2 pt 51.19 72.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.588 2.355 . . . . 0.0 114.478 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 78.92 66.1 0.19 Allowed Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 128.293 2.637 . . . . 0.0 113.202 165.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -81.95 7.48 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.169 3.246 . . . . 0.0 114.099 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 tptt . . . . . 0 CA--C 1.55 0.952 0 CA-C-N 119.631 1.105 . . . . 0.0 111.521 177.163 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 114.796 0.678 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -76.18 -10.72 59.63 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.727 1.264 . . . . 0.0 112.715 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.61 -7.72 11.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.563 1.145 . . . . 0.0 112.724 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -68.91 1.48 3.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.233 1.413 . . . . 0.0 113.927 165.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -45.5 -43.72 11.9 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.687 1.595 . . . . 0.0 113.146 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.316 2.3 pt 154.38 118.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 1 C-N-CA 132.638 4.375 . . . . 0.0 110.991 140.676 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? 74.91 64.17 0.27 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.007 2.523 . . . . 0.0 112.074 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.06 100.23 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.785 2.99 . . . . 0.0 110.269 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt . . . . . 0 N--CA 1.483 1.175 0 C-N-CA 125.8 1.64 . . . . 0.0 113.816 -175.137 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.426 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -78.87 -27.99 44.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.776 0.788 . . . . 0.0 111.237 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 7' ' ' ARG . 62.1 mt -67.82 3.16 1.58 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.703 1.201 . . . . 0.0 113.802 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -66.25 34.8 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.298 1.839 . . . . 0.0 113.603 167.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -92.52 -11.61 34.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.494 1.918 . . . . 0.0 113.215 168.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.2 pt 175.11 123.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 130.277 3.431 . . . . 0.0 109.917 165.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.16 49.94 0.52 Allowed Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 166.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.27 109.22 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.771 2.314 . . . . 0.0 111.813 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 125.073 1.349 . . . . 0.0 112.521 -177.319 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.041 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -68.02 -2.92 8.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.883 0.873 . . . . 0.0 113.238 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 7' ' ' ARG . 23.4 mt -76.54 -10.75 59.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.022 1.329 . . . . 0.0 112.097 171.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -70.32 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.414 1.486 . . . . 0.0 114.085 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 5' ' ' LEU . 44.6 ptt85 -76.82 44.98 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.712 2.805 . . . . 0.0 113.417 -175.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.291 42.5 pt 51.28 82.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 127.169 2.188 . . . . 0.0 114.356 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 83.48 70.15 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.159 2.584 . . . . 0.0 112.88 166.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.75 7.12 1.71 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.409 3.406 . . . . 0.0 115.088 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.274 1.429 . . . . 0.0 112.019 167.307 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.092 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -139.25 -8.18 1.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.499 1.649 . . . . 0.0 114.412 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.63 -10.41 3.55 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 119.764 -1.835 . . . . 0.0 112.35 161.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -49.7 -13.98 0.11 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.692 2.397 . . . . 0.0 116.006 161.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -57.53 -15.25 6.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.119 0.968 . . . . 0.0 112.99 168.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.32 123.63 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.195 -0.941 . . . . 0.0 109.596 146.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 74.71 82.12 0.13 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 128.934 2.893 . . . . 0.0 111.453 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.46 31.84 0.38 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.668 3.579 . . . . 0.0 114.096 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt . . . . . 0 N--CA 1.479 0.987 0 C-N-CA 126.498 1.919 . . . . 0.0 114.712 -178.828 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -67.0 -26.17 66.66 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.646 0.779 . . . . 0.0 111.98 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.19 -8.99 4.08 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -70.8 73.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.832 1.196 . . . . 0.0 110.64 161.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -90.04 -0.12 57.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.418 1.887 . . . . 0.0 113.441 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 mm 66.96 33.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.001 1.72 . . . . 0.0 110.05 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -120.05 85.99 36.2 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 128.036 2.534 . . . . 0.0 108.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.8 40.47 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.411 3.407 . . . . 0.0 111.865 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 mptt . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 113.258 -178.791 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.852 0.834 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.65 51.97 0.63 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.948 1.737 . . . . 0.0 111.139 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.78 -15.02 19.82 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.724 1.631 . . . . 0.0 115.31 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -127.28 13.42 7.14 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 119.025 1.412 . . . . 0.0 112.924 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -70.02 -9.64 55.97 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 119.451 -2.031 . . . . 0.0 111.317 158.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -46.4 -20.27 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.558 2.743 . . . . 0.0 115.337 161.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -48.68 -22.93 0.87 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.653 1.581 . . . . 0.0 114.412 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -129.97 134.44 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.328 1.051 . . . . 0.0 108.932 152.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? 60.29 72.27 0.76 Allowed Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.487 2.315 . . . . 0.0 112.586 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.66 22.47 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.41 4.073 . . . . 0.0 115.798 -174.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -135.96 14.01 3.35 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.54 -1.35 . . . . 0.0 112.745 170.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.9 tp -79.0 -13.33 59.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.443 1.497 . . . . 0.0 114.071 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.918 2.087 . . . . 0.0 113.306 -176.625 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 15.1 p90 . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.812 0.815 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.14 6.8 87.71 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 116.104 1.201 . . . . 0.0 116.104 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.23 -24.48 68.97 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.031 1.416 . . . . 0.0 115.775 -165.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -116.19 -20.9 9.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.779 1.632 . . . . 0.0 111.815 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.95 -11.36 2.34 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.963 -1.086 . . . . 0.0 112.983 166.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -41.36 -15.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.849 2.059 . . . . 0.0 116.109 153.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -18.31 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.341 1.856 . . . . 0.0 115.722 171.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.2 pt -129.07 137.06 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 149.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 68.92 58.32 0.62 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.426 1.89 . . . . 0.0 113.338 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.24 40.98 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.876 1 C-N-CA 126.55 4.833 . . . . 0.0 114.715 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -165.86 26.99 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.067 2.147 . . . . 0.0 111.455 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.42 37.09 0.28 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.659 1.984 . . . . 0.0 110.595 -177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.2 mttp . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.954 1.702 . . . . 0.0 112.665 178.036 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 81.5 t80 . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 122.218 1.009 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.73 61.51 0.29 Allowed Glycine 0 CA--C 1.52 0.391 0 O-C-N 121.172 -0.955 . . . . 0.0 113.818 -167.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.97 -31.6 65.18 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.738 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -121.29 -15.32 8.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.706 1.202 . . . . 0.0 112.837 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.7 -2.7 5.26 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.563 -1.336 . . . . 0.0 112.363 165.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -40.47 -23.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.892 2.877 . . . . 0.0 114.014 156.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -55.71 28.9 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 130.692 3.597 . . . . 0.0 115.784 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 mt 62.11 28.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.245 -2.159 . . . . 0.0 111.065 -176.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -115.26 60.73 1.41 Allowed Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 120.68 -1.263 . . . . 0.0 112.146 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -80.24 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 124.622 3.548 . . . . 0.0 113.437 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -81.34 -4.45 55.71 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.537 1.535 . . . . 0.0 114.092 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 78.9 mt -126.78 52.75 1.74 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.157 2.183 . . . . 0.0 109.332 169.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.5 tptt . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.926 1.69 . . . . 0.0 112.159 -179.334 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.78 27.73 52.96 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.668 -0.645 . . . . 0.0 114.344 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.51 -100.5 0.47 Allowed Glycine 0 N--CA 1.467 0.721 0 C-N-CA 125.181 1.372 . . . . 0.0 110.582 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -60.58 -16.49 38.49 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.5 mt -53.79 -12.22 0.5 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.692 1.197 . . . . 0.0 113.612 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -49.5 -16.16 0.19 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.413 1.485 . . . . 0.0 114.721 161.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -56.48 -28.71 60.46 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.555 1.142 . . . . 0.0 112.764 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 pt -169.76 113.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.18 2.192 . . . . 0.0 109.598 161.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 57.04 83.44 0.22 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.362 1.865 . . . . 0.0 112.275 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.26 1.52 4.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.195 3.263 . . . . 0.0 115.895 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -133.02 32.16 3.79 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.416 1.462 . . . . 0.0 112.408 164.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 64.2 mt 78.93 -29.72 0.15 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 129.278 3.031 . . . . 0.0 113.912 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 C--O 1.25 1.101 0 C-N-CA 126.784 2.034 . . . . 0.0 111.565 176.6 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 9.8 t80 . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 121.564 0.697 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.15 16.6 0.44 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.412 1.482 . . . . 0.0 116.11 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 120.27 -5.86 12.0 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 173.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -98.57 -3.72 35.69 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.348 2.074 . . . . 0.0 113.126 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.8 -7.23 32.25 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.594 -1.316 . . . . 0.0 112.332 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 5.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.559 2.344 . . . . 0.0 116.077 170.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -75.92 40.72 0.2 Allowed 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.116 -1.615 . . . . 0.0 115.04 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.341 36.2 pt 51.19 72.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.588 2.355 . . . . 0.0 114.478 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 78.92 66.1 0.19 Allowed Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 128.293 2.637 . . . . 0.0 113.202 165.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -81.95 7.48 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.169 3.246 . . . . 0.0 114.099 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -121.66 24.67 9.66 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.631 1.105 . . . . 0.0 111.521 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.18 -11.22 59.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.434 -1.416 . . . . 0.0 114.318 -168.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.543 1.137 . . . . 0.0 113.49 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.7 p90 . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.14 20.83 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.813 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.76 -44.46 0.22 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 118.451 1.126 . . . . 0.0 114.796 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -76.18 -10.72 59.63 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.727 1.264 . . . . 0.0 112.715 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.61 -7.72 11.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.563 1.145 . . . . 0.0 112.724 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -68.91 1.48 3.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.233 1.413 . . . . 0.0 113.927 165.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -45.5 -43.72 11.9 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.687 1.595 . . . . 0.0 113.146 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.316 2.3 pt 154.38 118.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 1 C-N-CA 132.638 4.375 . . . . 0.0 110.991 140.676 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? 74.91 64.17 0.27 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.007 2.523 . . . . 0.0 112.074 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.06 100.23 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.785 2.99 . . . . 0.0 110.269 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt 60.78 11.14 3.02 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.8 1.64 . . . . 0.0 113.816 -175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.2 mt -112.1 37.37 3.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.246 2.218 . . . . 0.0 110.357 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 126.262 1.825 . . . . 0.0 111.372 -172.789 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.82 0.343 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.25 -3.93 20.92 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 117.292 1.677 . . . . 0.0 117.292 167.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.39 -49.07 4.31 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-N 119.584 1.692 . . . . 0.0 113.426 -169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -78.87 -27.99 44.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.776 0.788 . . . . 0.0 111.237 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 7' ' ' ARG . 62.1 mt -67.82 3.16 1.58 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.703 1.201 . . . . 0.0 113.802 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -66.25 34.8 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.298 1.839 . . . . 0.0 113.603 167.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -92.52 -11.61 34.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.494 1.918 . . . . 0.0 113.215 168.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.2 pt 175.11 123.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 130.277 3.431 . . . . 0.0 109.917 165.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.16 49.94 0.52 Allowed Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 166.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.27 109.22 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.771 2.314 . . . . 0.0 111.813 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm 57.7 35.84 26.0 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.073 1.349 . . . . 0.0 112.521 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.5 mt -124.5 34.27 5.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.692 1.597 . . . . 0.0 112.498 -174.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 125.613 1.565 . . . . 0.0 111.847 166.672 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 12.9 p90 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.25 -12.29 49.32 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.419 1.009 . . . . 0.0 114.319 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.01 -66.54 3.58 Favored Glycine 0 N--CA 1.472 1.041 0 CA-C-N 119.116 1.458 . . . . 0.0 112.479 173.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -68.02 -2.92 8.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.883 0.873 . . . . 0.0 113.238 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 7' ' ' ARG . 23.4 mt -76.54 -10.75 59.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.022 1.329 . . . . 0.0 112.097 171.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -70.32 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.414 1.486 . . . . 0.0 114.085 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 5' ' ' LEU . 44.6 ptt85 -76.82 44.98 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.712 2.805 . . . . 0.0 113.417 -175.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.291 42.5 pt 51.28 82.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 127.169 2.188 . . . . 0.0 114.356 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 83.48 70.15 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.159 2.584 . . . . 0.0 112.88 166.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.75 7.12 1.71 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.409 3.406 . . . . 0.0 115.088 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -140.68 37.15 1.82 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.274 1.429 . . . . 0.0 112.019 167.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 tp -60.1 -25.0 65.08 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.342 -1.474 . . . . 0.0 113.532 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.61 1.564 . . . . 0.0 112.661 178.873 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 121.224 0.535 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.57 -24.15 73.85 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 120.704 -1.248 . . . . 0.0 114.903 -171.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.95 -7.1 44.24 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.451 1.501 . . . . 0.0 116.143 168.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -139.25 -8.18 1.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.499 1.649 . . . . 0.0 114.412 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.63 -10.41 3.55 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 119.764 -1.835 . . . . 0.0 112.35 161.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -49.7 -13.98 0.11 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.692 2.397 . . . . 0.0 116.006 161.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -57.53 -15.25 6.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.119 0.968 . . . . 0.0 112.99 168.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.32 123.63 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.195 -0.941 . . . . 0.0 109.596 146.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 74.71 82.12 0.13 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 128.934 2.893 . . . . 0.0 111.453 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.46 31.84 0.38 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.668 3.579 . . . . 0.0 114.096 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt 59.93 8.52 1.44 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.498 1.919 . . . . 0.0 114.712 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.3 tp -155.02 46.52 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.269 1.828 . . . . 0.0 109.438 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 127.859 2.463 . . . . 0.0 109.624 -176.884 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 14.0 p90 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.11 18.67 78.24 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.09 -1.006 . . . . 0.0 115.175 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.06 -72.86 1.06 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.277 1.418 . . . . 0.0 111.404 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -67.0 -26.17 66.66 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.646 0.779 . . . . 0.0 111.98 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.19 -8.99 4.08 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -70.8 73.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.832 1.196 . . . . 0.0 110.64 161.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -90.04 -0.12 57.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.418 1.887 . . . . 0.0 113.441 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 mm 66.96 33.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.001 1.72 . . . . 0.0 110.05 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -120.05 85.99 36.2 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 128.036 2.534 . . . . 0.0 108.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.8 40.47 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.411 3.407 . . . . 0.0 111.865 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 62.76 17.61 9.98 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 113.258 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.52 10.19 5.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.479 2.312 . . . . 0.0 112.358 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt . . . . . 0 C--O 1.249 1.059 0 C-N-CA 127.126 2.17 . . . . 0.0 111.797 -179.856 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.101 0 CA-C-O 118.898 -0.946 . . . . 0.0 115.31 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -127.28 13.42 7.14 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 119.025 1.412 . . . . 0.0 112.924 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -70.02 -9.64 55.97 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 119.451 -2.031 . . . . 0.0 111.317 158.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -46.4 -20.27 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.558 2.743 . . . . 0.0 115.337 161.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -48.68 -22.93 0.87 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.653 1.581 . . . . 0.0 114.412 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -129.97 134.44 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.328 1.051 . . . . 0.0 108.932 152.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? 60.29 72.27 0.76 Allowed Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.487 2.315 . . . . 0.0 112.586 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.66 22.47 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.41 4.073 . . . . 0.0 115.798 -174.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? . . . . . 0 CA--C 1.547 0.847 0 O-C-N 120.54 -1.35 . . . . 0.0 112.745 170.231 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.137 0 N-CA-C 115.775 1.07 . . . . 0.0 115.775 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -116.19 -20.9 9.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.779 1.632 . . . . 0.0 111.815 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.95 -11.36 2.34 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.963 -1.086 . . . . 0.0 112.983 166.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -41.36 -15.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.849 2.059 . . . . 0.0 116.109 153.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -18.31 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.341 1.856 . . . . 0.0 115.722 171.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.2 pt -129.07 137.06 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 149.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 68.92 58.32 0.62 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.426 1.89 . . . . 0.0 113.338 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.24 40.98 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.876 1 C-N-CA 126.55 4.833 . . . . 0.0 114.715 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttp . . . . . 0 CA--C 1.545 0.771 0 C-N-CA 127.067 2.147 . . . . 0.0 111.455 175.497 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.299 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.738 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -121.29 -15.32 8.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.706 1.202 . . . . 0.0 112.837 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.7 -2.7 5.26 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.563 -1.336 . . . . 0.0 112.363 165.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -40.47 -23.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.892 2.877 . . . . 0.0 114.014 156.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -55.71 28.9 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 130.692 3.597 . . . . 0.0 115.784 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 mt 62.11 28.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.245 -2.159 . . . . 0.0 111.065 -176.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -115.26 60.73 1.41 Allowed Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 120.68 -1.263 . . . . 0.0 112.146 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -80.24 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 124.622 3.548 . . . . 0.0 113.437 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 CA--C 1.552 1.024 0 C-N-CA 125.537 1.535 . . . . 0.0 114.092 175.423 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -60.58 -16.49 38.49 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.5 mt -53.79 -12.22 0.5 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.692 1.197 . . . . 0.0 113.612 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -49.5 -16.16 0.19 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.413 1.485 . . . . 0.0 114.721 161.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -56.48 -28.71 60.46 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.555 1.142 . . . . 0.0 112.764 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 pt -169.76 113.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.18 2.192 . . . . 0.0 109.598 161.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 57.04 83.44 0.22 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.362 1.865 . . . . 0.0 112.275 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.26 1.52 4.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.195 3.263 . . . . 0.0 115.895 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttm . . . . . 0 N--CA 1.478 0.95 0 CA-C-N 120.416 1.462 . . . . 0.0 112.408 164.889 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.187 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -98.57 -3.72 35.69 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.348 2.074 . . . . 0.0 113.126 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.8 -7.23 32.25 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.594 -1.316 . . . . 0.0 112.332 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 5.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.559 2.344 . . . . 0.0 116.077 170.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -75.92 40.72 0.2 Allowed 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.116 -1.615 . . . . 0.0 115.04 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.341 36.2 pt 51.19 72.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.588 2.355 . . . . 0.0 114.478 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 78.92 66.1 0.19 Allowed Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 128.293 2.637 . . . . 0.0 113.202 165.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -81.95 7.48 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.169 3.246 . . . . 0.0 114.099 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 tptt . . . . . 0 CA--C 1.55 0.952 0 CA-C-N 119.631 1.105 . . . . 0.0 111.521 177.163 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 114.796 0.678 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -76.18 -10.72 59.63 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.727 1.264 . . . . 0.0 112.715 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.61 -7.72 11.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.563 1.145 . . . . 0.0 112.724 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -68.91 1.48 3.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.233 1.413 . . . . 0.0 113.927 165.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -45.5 -43.72 11.9 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.687 1.595 . . . . 0.0 113.146 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.316 2.3 pt 154.38 118.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 1 C-N-CA 132.638 4.375 . . . . 0.0 110.991 140.676 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? 74.91 64.17 0.27 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.007 2.523 . . . . 0.0 112.074 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.06 100.23 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.785 2.99 . . . . 0.0 110.269 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt . . . . . 0 N--CA 1.483 1.175 0 C-N-CA 125.8 1.64 . . . . 0.0 113.816 -175.137 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.426 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -78.87 -27.99 44.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.776 0.788 . . . . 0.0 111.237 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 7' ' ' ARG . 62.1 mt -67.82 3.16 1.58 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.703 1.201 . . . . 0.0 113.802 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -66.25 34.8 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.298 1.839 . . . . 0.0 113.603 167.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -92.52 -11.61 34.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.494 1.918 . . . . 0.0 113.215 168.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.2 pt 175.11 123.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 130.277 3.431 . . . . 0.0 109.917 165.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.16 49.94 0.52 Allowed Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 166.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.27 109.22 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.771 2.314 . . . . 0.0 111.813 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 125.073 1.349 . . . . 0.0 112.521 -177.319 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.041 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -68.02 -2.92 8.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.883 0.873 . . . . 0.0 113.238 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.54 -10.75 59.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.022 1.329 . . . . 0.0 112.097 171.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -70.32 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.414 1.486 . . . . 0.0 114.085 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -76.82 44.98 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.712 2.805 . . . . 0.0 113.417 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.291 42.5 pt 51.28 82.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 127.169 2.188 . . . . 0.0 114.356 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 83.48 70.15 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.159 2.584 . . . . 0.0 112.88 166.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.75 7.12 1.71 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.409 3.406 . . . . 0.0 115.088 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.274 1.429 . . . . 0.0 112.019 167.307 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.092 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -139.25 -8.18 1.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.499 1.649 . . . . 0.0 114.412 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.63 -10.41 3.55 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 119.764 -1.835 . . . . 0.0 112.35 161.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -49.7 -13.98 0.11 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.692 2.397 . . . . 0.0 116.006 161.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -57.53 -15.25 6.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.119 0.968 . . . . 0.0 112.99 168.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.32 123.63 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.195 -0.941 . . . . 0.0 109.596 146.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 74.71 82.12 0.13 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 128.934 2.893 . . . . 0.0 111.453 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.46 31.84 0.38 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.668 3.579 . . . . 0.0 114.096 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt . . . . . 0 N--CA 1.479 0.987 0 C-N-CA 126.498 1.919 . . . . 0.0 114.712 -178.828 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -67.0 -26.17 66.66 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.646 0.779 . . . . 0.0 111.98 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.19 -8.99 4.08 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -70.8 73.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.832 1.196 . . . . 0.0 110.64 161.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -90.04 -0.12 57.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.418 1.887 . . . . 0.0 113.441 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 mm 66.96 33.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.001 1.72 . . . . 0.0 110.05 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -120.05 85.99 36.2 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 128.036 2.534 . . . . 0.0 108.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.8 40.47 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.411 3.407 . . . . 0.0 111.865 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 mptt . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 113.258 -178.791 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.852 0.834 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.65 51.97 0.63 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.948 1.737 . . . . 0.0 111.139 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.78 -15.02 19.82 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.724 1.631 . . . . 0.0 115.31 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -127.28 13.42 7.14 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 119.025 1.412 . . . . 0.0 112.924 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -70.02 -9.64 55.97 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 119.451 -2.031 . . . . 0.0 111.317 158.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -46.4 -20.27 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.558 2.743 . . . . 0.0 115.337 161.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -48.68 -22.93 0.87 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.653 1.581 . . . . 0.0 114.412 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -129.97 134.44 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.328 1.051 . . . . 0.0 108.932 152.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? 60.29 72.27 0.76 Allowed Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.487 2.315 . . . . 0.0 112.586 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.66 22.47 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.41 4.073 . . . . 0.0 115.798 -174.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -135.96 14.01 3.35 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.54 -1.35 . . . . 0.0 112.745 170.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.9 tp -79.0 -13.33 59.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.443 1.497 . . . . 0.0 114.071 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.918 2.087 . . . . 0.0 113.306 -176.625 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 15.1 p90 . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.812 0.815 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.14 6.8 87.71 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 116.104 1.201 . . . . 0.0 116.104 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.23 -24.48 68.97 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.031 1.416 . . . . 0.0 115.775 -165.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -116.19 -20.9 9.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.779 1.632 . . . . 0.0 111.815 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.95 -11.36 2.34 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.963 -1.086 . . . . 0.0 112.983 166.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -41.36 -15.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.849 2.059 . . . . 0.0 116.109 153.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -18.31 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.341 1.856 . . . . 0.0 115.722 171.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.2 pt -129.07 137.06 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 149.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 68.92 58.32 0.62 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.426 1.89 . . . . 0.0 113.338 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.24 40.98 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.876 1 C-N-CA 126.55 4.833 . . . . 0.0 114.715 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -165.86 26.99 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.067 2.147 . . . . 0.0 111.455 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.42 37.09 0.28 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.659 1.984 . . . . 0.0 110.595 -177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.2 mttp . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.954 1.702 . . . . 0.0 112.665 178.036 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 81.5 t80 . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 122.218 1.009 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.73 61.51 0.29 Allowed Glycine 0 CA--C 1.52 0.391 0 O-C-N 121.172 -0.955 . . . . 0.0 113.818 -167.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.97 -31.6 65.18 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.738 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -121.29 -15.32 8.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.706 1.202 . . . . 0.0 112.837 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.7 -2.7 5.26 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.563 -1.336 . . . . 0.0 112.363 165.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -40.47 -23.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.892 2.877 . . . . 0.0 114.014 156.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -55.71 28.9 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 130.692 3.597 . . . . 0.0 115.784 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 mt 62.11 28.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.245 -2.159 . . . . 0.0 111.065 -176.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -115.26 60.73 1.41 Allowed Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 120.68 -1.263 . . . . 0.0 112.146 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -80.24 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 124.622 3.548 . . . . 0.0 113.437 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -81.34 -4.45 55.71 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.537 1.535 . . . . 0.0 114.092 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 78.9 mt -126.78 52.75 1.74 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.157 2.183 . . . . 0.0 109.332 169.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.5 tptt . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.926 1.69 . . . . 0.0 112.159 -179.334 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.78 27.73 52.96 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.668 -0.645 . . . . 0.0 114.344 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.51 -100.5 0.47 Allowed Glycine 0 N--CA 1.467 0.721 0 C-N-CA 125.181 1.372 . . . . 0.0 110.582 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -60.58 -16.49 38.49 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.5 mt -53.79 -12.22 0.5 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.692 1.197 . . . . 0.0 113.612 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -49.5 -16.16 0.19 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.413 1.485 . . . . 0.0 114.721 161.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -56.48 -28.71 60.46 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.555 1.142 . . . . 0.0 112.764 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 pt -169.76 113.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.18 2.192 . . . . 0.0 109.598 161.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 57.04 83.44 0.22 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.362 1.865 . . . . 0.0 112.275 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.26 1.52 4.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.195 3.263 . . . . 0.0 115.895 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -133.02 32.16 3.79 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.416 1.462 . . . . 0.0 112.408 164.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 64.2 mt 78.93 -29.72 0.15 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 129.278 3.031 . . . . 0.0 113.912 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 C--O 1.25 1.101 0 C-N-CA 126.784 2.034 . . . . 0.0 111.565 176.6 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 9.8 t80 . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 121.564 0.697 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.15 16.6 0.44 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.412 1.482 . . . . 0.0 116.11 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 120.27 -5.86 12.0 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 173.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -98.57 -3.72 35.69 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.348 2.074 . . . . 0.0 113.126 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.8 -7.23 32.25 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.594 -1.316 . . . . 0.0 112.332 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 5.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.559 2.344 . . . . 0.0 116.077 170.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -75.92 40.72 0.2 Allowed 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.116 -1.615 . . . . 0.0 115.04 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.341 36.2 pt 51.19 72.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.588 2.355 . . . . 0.0 114.478 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 78.92 66.1 0.19 Allowed Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 128.293 2.637 . . . . 0.0 113.202 165.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -81.95 7.48 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.169 3.246 . . . . 0.0 114.099 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -121.66 24.67 9.66 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.631 1.105 . . . . 0.0 111.521 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.18 -11.22 59.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.434 -1.416 . . . . 0.0 114.318 -168.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.543 1.137 . . . . 0.0 113.49 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.7 p90 . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.14 20.83 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.813 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.76 -44.46 0.22 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 118.451 1.126 . . . . 0.0 114.796 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -76.18 -10.72 59.63 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.727 1.264 . . . . 0.0 112.715 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.61 -7.72 11.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.563 1.145 . . . . 0.0 112.724 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -68.91 1.48 3.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.233 1.413 . . . . 0.0 113.927 165.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -45.5 -43.72 11.9 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.687 1.595 . . . . 0.0 113.146 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.316 2.3 pt 154.38 118.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 1 C-N-CA 132.638 4.375 . . . . 0.0 110.991 140.676 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? 74.91 64.17 0.27 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.007 2.523 . . . . 0.0 112.074 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.06 100.23 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.785 2.99 . . . . 0.0 110.269 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt 60.78 11.14 3.02 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.8 1.64 . . . . 0.0 113.816 -175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.2 mt -112.1 37.37 3.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.246 2.218 . . . . 0.0 110.357 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 126.262 1.825 . . . . 0.0 111.372 -172.789 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.82 0.343 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.25 -3.93 20.92 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 117.292 1.677 . . . . 0.0 117.292 167.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.39 -49.07 4.31 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-N 119.584 1.692 . . . . 0.0 113.426 -169.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -78.87 -27.99 44.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.776 0.788 . . . . 0.0 111.237 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 7' ' ' ARG . 62.1 mt -67.82 3.16 1.58 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.703 1.201 . . . . 0.0 113.802 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -66.25 34.8 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.298 1.839 . . . . 0.0 113.603 167.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -92.52 -11.61 34.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.494 1.918 . . . . 0.0 113.215 168.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.2 pt 175.11 123.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 130.277 3.431 . . . . 0.0 109.917 165.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.16 49.94 0.52 Allowed Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 166.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.27 109.22 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.771 2.314 . . . . 0.0 111.813 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm 57.7 35.84 26.0 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.073 1.349 . . . . 0.0 112.521 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.5 mt -124.5 34.27 5.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.692 1.597 . . . . 0.0 112.498 -174.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 125.613 1.565 . . . . 0.0 111.847 166.672 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 12.9 p90 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.25 -12.29 49.32 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.419 1.009 . . . . 0.0 114.319 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.01 -66.54 3.58 Favored Glycine 0 N--CA 1.472 1.041 0 CA-C-N 119.116 1.458 . . . . 0.0 112.479 173.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -68.02 -2.92 8.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.883 0.873 . . . . 0.0 113.238 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.54 -10.75 59.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.022 1.329 . . . . 0.0 112.097 171.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -70.32 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.414 1.486 . . . . 0.0 114.085 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -76.82 44.98 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.712 2.805 . . . . 0.0 113.417 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.291 42.5 pt 51.28 82.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 127.169 2.188 . . . . 0.0 114.356 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 83.48 70.15 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.159 2.584 . . . . 0.0 112.88 166.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.75 7.12 1.71 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.409 3.406 . . . . 0.0 115.088 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -140.68 37.15 1.82 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.274 1.429 . . . . 0.0 112.019 167.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 tp -60.1 -25.0 65.08 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.342 -1.474 . . . . 0.0 113.532 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.61 1.564 . . . . 0.0 112.661 178.873 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 121.224 0.535 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.57 -24.15 73.85 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 120.704 -1.248 . . . . 0.0 114.903 -171.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.95 -7.1 44.24 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.451 1.501 . . . . 0.0 116.143 168.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -139.25 -8.18 1.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.499 1.649 . . . . 0.0 114.412 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.63 -10.41 3.55 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 119.764 -1.835 . . . . 0.0 112.35 161.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -49.7 -13.98 0.11 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.692 2.397 . . . . 0.0 116.006 161.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -57.53 -15.25 6.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.119 0.968 . . . . 0.0 112.99 168.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.32 123.63 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.195 -0.941 . . . . 0.0 109.596 146.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 74.71 82.12 0.13 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 128.934 2.893 . . . . 0.0 111.453 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.46 31.84 0.38 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.668 3.579 . . . . 0.0 114.096 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt 59.93 8.52 1.44 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.498 1.919 . . . . 0.0 114.712 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.3 tp -155.02 46.52 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.269 1.828 . . . . 0.0 109.438 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 127.859 2.463 . . . . 0.0 109.624 -176.884 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 14.0 p90 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.11 18.67 78.24 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.09 -1.006 . . . . 0.0 115.175 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.06 -72.86 1.06 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.277 1.418 . . . . 0.0 111.404 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -67.0 -26.17 66.66 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.646 0.779 . . . . 0.0 111.98 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.19 -8.99 4.08 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -70.8 73.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.832 1.196 . . . . 0.0 110.64 161.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -90.04 -0.12 57.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.418 1.887 . . . . 0.0 113.441 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 mm 66.96 33.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.001 1.72 . . . . 0.0 110.05 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -120.05 85.99 36.2 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 128.036 2.534 . . . . 0.0 108.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.8 40.47 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.411 3.407 . . . . 0.0 111.865 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 62.76 17.61 9.98 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 113.258 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.52 10.19 5.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.479 2.312 . . . . 0.0 112.358 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt . . . . . 0 C--O 1.249 1.059 0 C-N-CA 127.126 2.17 . . . . 0.0 111.797 -179.856 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.101 0 CA-C-O 118.898 -0.946 . . . . 0.0 115.31 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -127.28 13.42 7.14 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 119.025 1.412 . . . . 0.0 112.924 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -70.02 -9.64 55.97 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 119.451 -2.031 . . . . 0.0 111.317 158.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -46.4 -20.27 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.558 2.743 . . . . 0.0 115.337 161.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -48.68 -22.93 0.87 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.653 1.581 . . . . 0.0 114.412 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -129.97 134.44 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.328 1.051 . . . . 0.0 108.932 152.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? 60.29 72.27 0.76 Allowed Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.487 2.315 . . . . 0.0 112.586 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.66 22.47 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.41 4.073 . . . . 0.0 115.798 -174.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? . . . . . 0 CA--C 1.547 0.847 0 O-C-N 120.54 -1.35 . . . . 0.0 112.745 170.231 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.137 0 N-CA-C 115.775 1.07 . . . . 0.0 115.775 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -116.19 -20.9 9.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.779 1.632 . . . . 0.0 111.815 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.95 -11.36 2.34 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.963 -1.086 . . . . 0.0 112.983 166.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -41.36 -15.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.849 2.059 . . . . 0.0 116.109 153.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -18.31 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.341 1.856 . . . . 0.0 115.722 171.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.2 pt -129.07 137.06 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 149.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 68.92 58.32 0.62 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.426 1.89 . . . . 0.0 113.338 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.24 40.98 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.876 1 C-N-CA 126.55 4.833 . . . . 0.0 114.715 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttp . . . . . 0 CA--C 1.545 0.771 0 C-N-CA 127.067 2.147 . . . . 0.0 111.455 175.497 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.299 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.738 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -121.29 -15.32 8.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.706 1.202 . . . . 0.0 112.837 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.7 -2.7 5.26 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.563 -1.336 . . . . 0.0 112.363 165.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -40.47 -23.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.892 2.877 . . . . 0.0 114.014 156.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -55.71 28.9 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 130.692 3.597 . . . . 0.0 115.784 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 mt 62.11 28.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.245 -2.159 . . . . 0.0 111.065 -176.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -115.26 60.73 1.41 Allowed Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 120.68 -1.263 . . . . 0.0 112.146 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -80.24 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 124.622 3.548 . . . . 0.0 113.437 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 CA--C 1.552 1.024 0 C-N-CA 125.537 1.535 . . . . 0.0 114.092 175.423 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -60.58 -16.49 38.49 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.5 mt -53.79 -12.22 0.5 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.692 1.197 . . . . 0.0 113.612 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -49.5 -16.16 0.19 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.413 1.485 . . . . 0.0 114.721 161.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -56.48 -28.71 60.46 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.555 1.142 . . . . 0.0 112.764 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 pt -169.76 113.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.18 2.192 . . . . 0.0 109.598 161.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 57.04 83.44 0.22 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.362 1.865 . . . . 0.0 112.275 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.26 1.52 4.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.195 3.263 . . . . 0.0 115.895 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttm . . . . . 0 N--CA 1.478 0.95 0 CA-C-N 120.416 1.462 . . . . 0.0 112.408 164.889 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.187 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -98.57 -3.72 35.69 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.348 2.074 . . . . 0.0 113.126 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.8 -7.23 32.25 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.594 -1.316 . . . . 0.0 112.332 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 5.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.559 2.344 . . . . 0.0 116.077 170.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -75.92 40.72 0.2 Allowed 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.116 -1.615 . . . . 0.0 115.04 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.341 36.2 pt 51.19 72.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.588 2.355 . . . . 0.0 114.478 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 78.92 66.1 0.19 Allowed Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 128.293 2.637 . . . . 0.0 113.202 165.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -81.95 7.48 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.169 3.246 . . . . 0.0 114.099 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 tptt . . . . . 0 CA--C 1.55 0.952 0 CA-C-N 119.631 1.105 . . . . 0.0 111.521 177.163 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 114.796 0.678 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -76.18 -10.72 59.63 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.727 1.264 . . . . 0.0 112.715 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.61 -7.72 11.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.563 1.145 . . . . 0.0 112.724 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -68.91 1.48 3.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.233 1.413 . . . . 0.0 113.927 165.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -45.5 -43.72 11.9 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.687 1.595 . . . . 0.0 113.146 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.316 2.3 pt 154.38 118.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 1 C-N-CA 132.638 4.375 . . . . 0.0 110.991 140.676 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? 74.91 64.17 0.27 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.007 2.523 . . . . 0.0 112.074 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.06 100.23 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.785 2.99 . . . . 0.0 110.269 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt . . . . . 0 N--CA 1.483 1.175 0 C-N-CA 125.8 1.64 . . . . 0.0 113.816 -175.137 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.426 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -78.87 -27.99 44.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.776 0.788 . . . . 0.0 111.237 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 7' ' ' ARG . 62.1 mt -67.82 3.16 1.58 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.703 1.201 . . . . 0.0 113.802 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -66.25 34.8 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.298 1.839 . . . . 0.0 113.603 167.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -92.52 -11.61 34.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.494 1.918 . . . . 0.0 113.215 168.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.2 pt 175.11 123.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 130.277 3.431 . . . . 0.0 109.917 165.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.16 49.94 0.52 Allowed Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 166.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.27 109.22 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.771 2.314 . . . . 0.0 111.813 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 125.073 1.349 . . . . 0.0 112.521 -177.319 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.041 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -68.02 -2.92 8.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.883 0.873 . . . . 0.0 113.238 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.54 -10.75 59.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.022 1.329 . . . . 0.0 112.097 171.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -70.32 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.414 1.486 . . . . 0.0 114.085 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -76.82 44.98 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.712 2.805 . . . . 0.0 113.417 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.291 42.5 pt 51.28 82.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 127.169 2.188 . . . . 0.0 114.356 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 83.48 70.15 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.159 2.584 . . . . 0.0 112.88 166.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.75 7.12 1.71 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.409 3.406 . . . . 0.0 115.088 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.274 1.429 . . . . 0.0 112.019 167.307 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.092 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -139.25 -8.18 1.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.499 1.649 . . . . 0.0 114.412 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.63 -10.41 3.55 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 119.764 -1.835 . . . . 0.0 112.35 161.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -49.7 -13.98 0.11 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.692 2.397 . . . . 0.0 116.006 161.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -57.53 -15.25 6.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.119 0.968 . . . . 0.0 112.99 168.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.32 123.63 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.195 -0.941 . . . . 0.0 109.596 146.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 74.71 82.12 0.13 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 128.934 2.893 . . . . 0.0 111.453 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.46 31.84 0.38 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.668 3.579 . . . . 0.0 114.096 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt . . . . . 0 N--CA 1.479 0.987 0 C-N-CA 126.498 1.919 . . . . 0.0 114.712 -178.828 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -67.0 -26.17 66.66 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.646 0.779 . . . . 0.0 111.98 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.19 -8.99 4.08 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -70.8 73.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.832 1.196 . . . . 0.0 110.64 161.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -90.04 -0.12 57.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.418 1.887 . . . . 0.0 113.441 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 mm 66.96 33.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.001 1.72 . . . . 0.0 110.05 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -120.05 85.99 36.2 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 128.036 2.534 . . . . 0.0 108.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.8 40.47 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.411 3.407 . . . . 0.0 111.865 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 mptt . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 113.258 -178.791 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.852 0.834 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.65 51.97 0.63 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.948 1.737 . . . . 0.0 111.139 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.78 -15.02 19.82 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.724 1.631 . . . . 0.0 115.31 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -127.28 13.42 7.14 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 119.025 1.412 . . . . 0.0 112.924 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -70.02 -9.64 55.97 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 119.451 -2.031 . . . . 0.0 111.317 158.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -46.4 -20.27 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.558 2.743 . . . . 0.0 115.337 161.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -48.68 -22.93 0.87 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.653 1.581 . . . . 0.0 114.412 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 pt -129.97 134.44 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.328 1.051 . . . . 0.0 108.932 152.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? 60.29 72.27 0.76 Allowed Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.487 2.315 . . . . 0.0 112.586 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.66 22.47 0.46 Allowed 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.41 4.073 . . . . 0.0 115.798 -174.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -135.96 14.01 3.35 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.54 -1.35 . . . . 0.0 112.745 170.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.9 tp -79.0 -13.33 59.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.443 1.497 . . . . 0.0 114.071 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.918 2.087 . . . . 0.0 113.306 -176.625 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 15.1 p90 . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.812 0.815 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.14 6.8 87.71 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 116.104 1.201 . . . . 0.0 116.104 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.23 -24.48 68.97 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.031 1.416 . . . . 0.0 115.775 -165.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -116.19 -20.9 9.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.779 1.632 . . . . 0.0 111.815 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.95 -11.36 2.34 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.963 -1.086 . . . . 0.0 112.983 166.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -41.36 -15.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.849 2.059 . . . . 0.0 116.109 153.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.37 -18.31 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.341 1.856 . . . . 0.0 115.722 171.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.2 pt -129.07 137.06 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 149.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 68.92 58.32 0.62 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 126.426 1.89 . . . . 0.0 113.338 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.24 40.98 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.876 1 C-N-CA 126.55 4.833 . . . . 0.0 114.715 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -165.86 26.99 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.067 2.147 . . . . 0.0 111.455 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.42 37.09 0.28 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.659 1.984 . . . . 0.0 110.595 -177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.2 mttp . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.954 1.702 . . . . 0.0 112.665 178.036 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 81.5 t80 . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 122.218 1.009 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.73 61.51 0.29 Allowed Glycine 0 CA--C 1.52 0.391 0 O-C-N 121.172 -0.955 . . . . 0.0 113.818 -167.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.97 -31.6 65.18 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.738 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -121.29 -15.32 8.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.706 1.202 . . . . 0.0 112.837 168.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.7 -2.7 5.26 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.563 -1.336 . . . . 0.0 112.363 165.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -40.47 -23.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.892 2.877 . . . . 0.0 114.014 156.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -55.71 28.9 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 130.692 3.597 . . . . 0.0 115.784 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 mt 62.11 28.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.245 -2.159 . . . . 0.0 111.065 -176.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -115.26 60.73 1.41 Allowed Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 120.68 -1.263 . . . . 0.0 112.146 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -80.24 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 124.622 3.548 . . . . 0.0 113.437 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -81.34 -4.45 55.71 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.537 1.535 . . . . 0.0 114.092 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 78.9 mt -126.78 52.75 1.74 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.157 2.183 . . . . 0.0 109.332 169.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.5 tptt . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.926 1.69 . . . . 0.0 112.159 -179.334 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.78 27.73 52.96 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.668 -0.645 . . . . 0.0 114.344 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.51 -100.5 0.47 Allowed Glycine 0 N--CA 1.467 0.721 0 C-N-CA 125.181 1.372 . . . . 0.0 110.582 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -60.58 -16.49 38.49 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.5 mt -53.79 -12.22 0.5 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.692 1.197 . . . . 0.0 113.612 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -49.5 -16.16 0.19 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.413 1.485 . . . . 0.0 114.721 161.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -56.48 -28.71 60.46 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.555 1.142 . . . . 0.0 112.764 169.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 pt -169.76 113.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.18 2.192 . . . . 0.0 109.598 161.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 57.04 83.44 0.22 Allowed Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.362 1.865 . . . . 0.0 112.275 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.26 1.52 4.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.195 3.263 . . . . 0.0 115.895 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -133.02 32.16 3.79 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.416 1.462 . . . . 0.0 112.408 164.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 64.2 mt 78.93 -29.72 0.15 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 129.278 3.031 . . . . 0.0 113.912 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 C--O 1.25 1.101 0 C-N-CA 126.784 2.034 . . . . 0.0 111.565 176.6 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 9.8 t80 . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 121.564 0.697 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.15 16.6 0.44 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.412 1.482 . . . . 0.0 116.11 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 120.27 -5.86 12.0 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 173.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -98.57 -3.72 35.69 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.348 2.074 . . . . 0.0 113.126 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.8 -7.23 32.25 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.594 -1.316 . . . . 0.0 112.332 165.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 5.66 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.559 2.344 . . . . 0.0 116.077 170.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -75.92 40.72 0.2 Allowed 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.116 -1.615 . . . . 0.0 115.04 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.341 36.2 pt 51.19 72.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.588 2.355 . . . . 0.0 114.478 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 78.92 66.1 0.19 Allowed Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 128.293 2.637 . . . . 0.0 113.202 165.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -81.95 7.48 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.169 3.246 . . . . 0.0 114.099 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -121.66 24.67 9.66 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.631 1.105 . . . . 0.0 111.521 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.18 -11.22 59.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.434 -1.416 . . . . 0.0 114.318 -168.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.543 1.137 . . . . 0.0 113.49 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.7 p90 . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.34 33.14 20.83 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.813 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.76 -44.46 0.22 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 118.451 1.126 . . . . 0.0 114.796 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -76.18 -10.72 59.63 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.727 1.264 . . . . 0.0 112.715 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.61 -7.72 11.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.563 1.145 . . . . 0.0 112.724 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -68.91 1.48 3.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.233 1.413 . . . . 0.0 113.927 165.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -45.5 -43.72 11.9 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.687 1.595 . . . . 0.0 113.146 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.316 2.3 pt 154.38 118.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 1 C-N-CA 132.638 4.375 . . . . 0.0 110.991 140.676 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? 74.91 64.17 0.27 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.007 2.523 . . . . 0.0 112.074 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.06 100.23 1.08 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.785 2.99 . . . . 0.0 110.269 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt 60.78 11.14 3.02 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.8 1.64 . . . . 0.0 113.816 -175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.2 mt -112.1 37.37 3.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.246 2.218 . . . . 0.0 110.357 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 126.262 1.825 . . . . 0.0 111.372 -172.789 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.82 0.343 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.25 -3.93 20.92 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 117.292 1.677 . . . . 0.0 117.292 167.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.39 -49.07 4.31 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-N 119.584 1.692 . . . . 0.0 113.426 -169.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -78.87 -27.99 44.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.776 0.788 . . . . 0.0 111.237 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 7' ' ' ARG . 62.1 mt -67.82 3.16 1.58 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.703 1.201 . . . . 0.0 113.802 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -66.25 34.8 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.298 1.839 . . . . 0.0 113.603 167.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -92.52 -11.61 34.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.494 1.918 . . . . 0.0 113.215 168.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.2 pt 175.11 123.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 130.277 3.431 . . . . 0.0 109.917 165.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.16 49.94 0.52 Allowed Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 166.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.27 109.22 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.771 2.314 . . . . 0.0 111.813 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm 57.7 35.84 26.0 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.073 1.349 . . . . 0.0 112.521 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.5 mt -124.5 34.27 5.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.692 1.597 . . . . 0.0 112.498 -174.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 125.613 1.565 . . . . 0.0 111.847 166.672 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 12.9 p90 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.25 -12.29 49.32 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.419 1.009 . . . . 0.0 114.319 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.01 -66.54 3.58 Favored Glycine 0 N--CA 1.472 1.041 0 CA-C-N 119.116 1.458 . . . . 0.0 112.479 173.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -68.02 -2.92 8.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.883 0.873 . . . . 0.0 113.238 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.54 -10.75 59.62 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.022 1.329 . . . . 0.0 112.097 171.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -70.32 26.8 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.414 1.486 . . . . 0.0 114.085 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -76.82 44.98 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.712 2.805 . . . . 0.0 113.417 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.291 42.5 pt 51.28 82.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 127.169 2.188 . . . . 0.0 114.356 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 83.48 70.15 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.159 2.584 . . . . 0.0 112.88 166.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.75 7.12 1.71 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.409 3.406 . . . . 0.0 115.088 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -140.68 37.15 1.82 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.274 1.429 . . . . 0.0 112.019 167.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 tp -60.1 -25.0 65.08 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.342 -1.474 . . . . 0.0 113.532 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.61 1.564 . . . . 0.0 112.661 178.873 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 121.224 0.535 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.57 -24.15 73.85 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 120.704 -1.248 . . . . 0.0 114.903 -171.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.95 -7.1 44.24 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.451 1.501 . . . . 0.0 116.143 168.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -139.25 -8.18 1.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.499 1.649 . . . . 0.0 114.412 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.63 -10.41 3.55 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 119.764 -1.835 . . . . 0.0 112.35 161.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -49.7 -13.98 0.11 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.692 2.397 . . . . 0.0 116.006 161.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -57.53 -15.25 6.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.119 0.968 . . . . 0.0 112.99 168.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.32 123.63 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.195 -0.941 . . . . 0.0 109.596 146.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 74.71 82.12 0.13 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 128.934 2.893 . . . . 0.0 111.453 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.46 31.84 0.38 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.668 3.579 . . . . 0.0 114.096 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt 59.93 8.52 1.44 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.498 1.919 . . . . 0.0 114.712 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.3 tp -155.02 46.52 0.52 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.269 1.828 . . . . 0.0 109.438 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 127.859 2.463 . . . . 0.0 109.624 -176.884 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 14.0 p90 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.11 18.67 78.24 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.09 -1.006 . . . . 0.0 115.175 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.06 -72.86 1.06 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.277 1.418 . . . . 0.0 111.404 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -67.0 -26.17 66.66 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.646 0.779 . . . . 0.0 111.98 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.19 -8.99 4.08 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -70.8 73.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.832 1.196 . . . . 0.0 110.64 161.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -90.04 -0.12 57.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.418 1.887 . . . . 0.0 113.441 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 mm 66.96 33.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.001 1.72 . . . . 0.0 110.05 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -120.05 85.99 36.2 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 128.036 2.534 . . . . 0.0 108.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.8 40.47 0.96 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.411 3.407 . . . . 0.0 111.865 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 62.76 17.61 9.98 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 113.258 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.6 mt -130.52 10.19 5.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.479 2.312 . . . . 0.0 112.358 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt . . . . . 0 C--O 1.249 1.059 0 C-N-CA 127.126 2.17 . . . . 0.0 111.797 -179.856 . . . . . . . . 0 0 . 1 stop_ save_